Directa Plus (GB:DCTA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Directa Plus, a key player in graphene nanoplatelet-based products, is launching a fundraising initiative aimed at generating between £6.8 million and £6.9 million to capitalize on significant growth opportunities. The fundraising includes a conditional placing and subscription, which will see the issue of over 38 million new shares, with Nant Capital LLC, the company’s largest shareholder, expressing substantial interest. The success of this fundraising, which is subject to shareholder approval, could mark a new phase of accelerated growth for the company.
For further insights into GB:DCTA stock, check out TipRanks’ Stock Analysis page.
